Wurtzite CoO: a direct band gap oxide suitable for a photovoltaic absorber.

A direct band gap of 1.6 eV has been identified in wurtzite CoO thin films, which matches the required value to achieve a theoretically high conversion efficiency solar cell. Its p-type conduction has been determined and an intense sub-gap absorption between 0.7 and 1.1 eV has been observed.

Room temperature self-assembled growth of vertically aligned columnar copper oxide nanocomposite thin films on unmatched substrates.

In this work, we report the self-assembled growth of vertically aligned columnar Cu2O + Cu4O3 nanocomposite thin films on glass and silicon substrates by reactive sputtering at room temperature. Microstructure analyses show that each phase in nanocomposite films has the columnar growth along the whole thickness, while each column exhibits the single phase characteristics. The local epitaxial growth behavior of Cu2O is thought to be responsible for such an unusual microstructure. The intermediate oxygen flow rate between those required to synthesize single phase Cu2O and Cu4O3 films produces some Cu2O nuclei, and then the local epitaxial growth provides a strong driving force to promote Cu2O nuclei to grow sequentially, giving rise to Cu2O columns along the whole thickness. Lower resistivity has been observed in such kind of nanocomposite thin films than that in single phase thin films, which may be due to the interface coupling between Cu2O and Cu4O3 columns.

Infrared Plasmonics with Conductive Ternary Nitrides.

Conductive transition metal nitrides are emerging as promising alternative plasmonic materials that are refractory and CMOS-compatible. In this work, we show that ternary transition metal nitrides of the B1 structure and consisting of a combination of group-IVb transition metal, such as Ti or Zr, and group III (Sc, Y, Al) or group II (Mg, Ca) elements can have tunable plasmonic activity in the infrared range in contrast to Ta-based ternary nitrides, which exhibit plasmonic performance in the visible and UV ranges. We consider the intrinsic quality factors of surface plasmon polariton for the ternary nitrides, and we calculate the dispersion of surface plasmon polariton and the field enhancement at the vicinity of nitride/silica interfaces. Based on these calculations, it is shown that among these nitrides the most promising are TixSc1-xN and TixMg1-xN. In particular, TixSc1-xN can have plasmonic activity in the usual telecom bands at 850, 1300, and 1550 nm. Still, these nitrides exhibit substantial electronic losses mostly due to fine crystalline grains that deteriorate the plasmonic field enhancement. This unequivocally calls for improved growth processes that would enable the fabrication of such ternary nitrides of high crystallinity.

Bacterial adhesion on biomedical surfaces covered by micrometric silver Islands.

A set of Cu-Mn-O and Ag-Cu-Mn-O films were sputter-deposited onto polished Ti-6Al-4V coupons and the microbiological adherence of Staphylococcus sp. was studied in these biomedical surfaces modified by using advanced ternary and quaternary oxides, these latter incorporated micrometric silver islands. Silver is known to have a natural biocidal character and its presence in the surface of Ti-6Al-4V forming large micrometric islands. In principle, predicted to enhance the antimicrobial properties of biomedical surfaces. Microbial adhesion tests were performed using collection strains and six clinical Staphylococcus aureus and Staphylococcus epidermidis strains. The adherence study was performed using a previously published protocol by Kinnari et al. Collection strains and clinical strains showed decreased adherence to modified materials; however, only on the clinical strains were there statistically significant differences between Cu-Mn-O and Ag-Cu-Mn-O containing silver islands. Nanocrystalline silver dissolves and releases both Ag(+) and Ag(0) whereas other silver sources release only Ag+. We can conclude that nanocrystalline silver coating, confirmed by XRD, appears to alter the biological properties of the solution, particularly antimicrobial activity.

Economic evaluation of risperidone in an outpatient population.

OBJECTIVE: To study the impact of risperidone use on the cost of services provided to severely mentally disabled outpatients and on hospital avoidance, and to analyze patterns in the use of concomitant medications as a surrogate marker of changes in adverse effects or patient well-being. METHODS: The patients were 31 clients of community mental health centers who had received risperidone for at least three months and for whom there were at least three months of available data on medication use and costs prior to risperidone treatment. The actual average monthly costs of community mental health services obtained from a county mental health board were compared with service costs prior to use of risperidone, using the patients as their own controls, and compared with a control group. RESULTS: Compared with the pre-risperidone period, the average cost per month of providing mental health services increased by 73.7% during the risperidone treatment period. Compared with the pre-risperidone period, the average total cost of treatment (including medications) increased by 113.3% during the risperidone treatment period. The average total cost of medication increased by 422.8% during the risperidone treatment period compared with the pre-risperidone treatment period. CONCLUSIONS: From the perspective of the community mental health board, risperidone treatment did not reduce the cost of services provided to these clients, but substantially and significantly increased total costs, including medication.

Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic.

We hypothesized that a pharmacist-provided comprehensive education program in conjunction with care provided by a pulmonologist would lead to improved economic, clinical, and humanistic outcomes in adults with asthma, compared with similar patients receiving care from a pulmonologist alone. The experimental group reported receiving more information about asthma self-management (p=0.001), were more likely to monitor peak flow readings (p=0.004), and had increased satisfaction with care, and perceived higher quality of care. Both groups had less lost productivity, fewer emergency department visits, fewer hospitalizations, and fewer physician visits, as well as improvement in symptoms scores within 45 days. Both groups improved in all functional status domains except the mental component score of the SF-12. Our results show a positive impact on outcomes in adults with asthma who received pharmaceutical care.